Do neutralizing antibody responses generated by human papillomavirus infections favor a better outcome of low-grade cervical lesions?
Ochi H, Matsumoto K, Kondo K, Oki A, Furuta R, Hirai Y, Yasugi T, Takatsuka N, Maeda H, Mitsuhashi A, Fujii T, Kawana K, Iwasaka T, Yaegashi N, Watanabe Y, Nagai Y, Kitagawa T, Kanda T, Yoshikawa H; Japan HPV And Cervical Cancer (JHACC) Study Group.
Ochi H, et al. Among authors: kawana k.
J Med Virol. 2012 Jul;84(7):1128-34. doi: 10.1002/jmv.23258.
J Med Virol. 2012.
PMID: 22585732